Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

by · The Cerbat Gem

StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the software maker’s stock.

Veradigm Price Performance

Shares of MDRX opened at $9.50 on Thursday. Veradigm has a 1-year low of $5.01 and a 1-year high of $11.80. The firm has a 50 day simple moving average of $9.98 and a 200-day simple moving average of $9.73.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRXFree Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles